Skip to main content

At Tactile Medical, a fundamental value is to earn a fair profit and return value for our shareholders


--

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Upcoming Events


More events are coming soon.

Recent News


Tactile Medical Announces Publication of Expert Opinion Consensus Statement in Phlebology Recommending the Use of Pneumatic Compression for Lymphedema

Consensus that Patients with Chronic Venous Insufficiency Should be Considered Lymphedema Patients MINNEAPOLIS , June 07, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the

Read more

Tactile Medical to Present at the William Blair 42nd Annual Growth Stock Conference

MINNEAPOLIS , May 25, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced that management will

Read more

Tactile Systems Technology, Inc. Reports First Quarter 2022 Financial Results; Reaffirms Full Year 2022 Outlook

First Quarter Revenue Increased 12% Year-Over-Year MINNEAPOLIS , May 02, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases

Read more